{"id":2192,"date":"2025-09-04T09:05:29","date_gmt":"2025-09-04T13:05:29","guid":{"rendered":"https:\/\/scienceweb.clemson.edu\/chg\/?p=2192"},"modified":"2025-09-11T09:24:53","modified_gmt":"2025-09-11T13:24:53","slug":"justin-gibson","status":"publish","type":"post","link":"https:\/\/scienceweb.clemson.edu\/ihg\/justin-gibson\/","title":{"rendered":"Justin Gibson"},"content":{"rendered":"<p>[et_pb_section][et_pb_row][et_pb_column type=&#8221;4_4&#8243;][et_pb_text]<\/p>\n<div id=\"attachment_2189\" style=\"width: 231px\" class=\"wp-caption alignright\"><img decoding=\"async\" aria-describedby=\"caption-attachment-2189\" class=\"size-medium wp-image-2189 lazyload\" title=\"J. Gibson Headshot (002)\" data-src=\"https:\/\/scienceweb.clemson.edu\/chg\/wp-content\/uploads\/sites\/4\/2025\/09\/J.-Gibson_Headshot-002-221x300.jpg\" alt=\"Male in Navy blazer with blue shirt standing in front of brick background.\" width=\"221\" height=\"300\" data-srcset=\"https:\/\/scienceweb.clemson.edu\/ihg\/wp-content\/uploads\/sites\/4\/2025\/09\/J.-Gibson_Headshot-002-221x300.jpg 221w, https:\/\/scienceweb.clemson.edu\/ihg\/wp-content\/uploads\/sites\/4\/2025\/09\/J.-Gibson_Headshot-002.jpg 392w\" data-sizes=\"(max-width: 221px) 100vw, 221px\" src=\"data:image\/svg+xml;base64,PHN2ZyB3aWR0aD0iMSIgaGVpZ2h0PSIxIiB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciPjwvc3ZnPg==\" style=\"--smush-placeholder-width: 221px; --smush-placeholder-aspect-ratio: 221\/300;\" \/><p id=\"caption-attachment-2189\" class=\"wp-caption-text\">J. Gibson Headshot (002)<\/p><\/div>\n<p>Graduate Student<\/p>\n<p><a href=\"mailto:jrg6@g.clemson.edu\">jrg6@g.clemson.edu<\/a><\/p>\n<h3><strong>Biosketch<\/strong><\/h3>\n<p>I am a second-year PhD student and graduate research assistant in the Cottle Lab at Clemson University\u2019s Bioengineering department. My research entails the elucidation of improving <em>ex vivo <\/em>gene therapy outcomes for the treatment of inherited metabolic liver diseases. I am currently leading several projects in the lab such as the role of donor age on the engraftment potential and proliferative capacity of transplanted hepatocytes, and the optimization of base-editing as an alternative to CRISPR-Cas9 therapy for liver disease treatments. Recently, I began the position of laboratory manager, guiding budget inspection and order approval as well as fostering research efficiency. I have just begun writing my literature review on the present translatability of gene therapy and am excited to continue along this path to push the frontiers of science.<\/p>\n<h3><strong>Research Interests<\/strong><\/h3>\n<p>I presented the poster, <em>Comparison of electroporation systems for CRISPR-Cas9 mediated gene-editing in primary hepatocytes for the correction of hereditary tyrosinemia type 1, <\/em>in the 2024 SC INBRE Science Symposium. I am also listed as a co-author on the research article, <em>One Shock, Not One Cure: Electroporation Reveals Disease-Specific Constraints in Hepatocyte Gene Editing Therapy <\/em>and as co-primary author on the peer-reviewed research article, <em>Validation of clinical-grade electroporation systems for CRISPR-Cas9 mediated gene therapy in primary hepatocytes for the correction of inherited metabolic liver disease<\/em>.<\/p>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section]<\/p>\n","protected":false},"excerpt":{"rendered":"<p><div class=\"et_pb_section et_pb_section_0 et_section_regular\" >\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t<\/div><div class=\"et_pb_row et_pb_row_0 et_pb_row_empty\">\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t<\/div><div class=\"et_pb_module et_pb_text et_pb_text_0  et_pb_text_align_left et_pb_bg_layout_light\">\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t<\/div> Graduate Student jrg6@g.clemson.edu Biosketch I am a second-year PhD student and graduate research assistant in the Cottle Lab at Clemson University\u2019s Bioengineering department. My research entails the elucidation of improving ex vivo gene therapy outcomes for the treatment of inherited metabolic liver diseases. I am currently leading several projects in the lab such as [&hellip;]<\/p>\n","protected":false},"author":32,"featured_media":2189,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"on","_et_pb_old_content":"[caption id=\"attachment_2189\" align=\"alignright\" width=\"221\"]<img class=\"size-medium wp-image-2189\" title=\"J. Gibson Headshot (002)\" src=\"https:\/\/scienceweb.clemson.edu\/chg\/wp-content\/uploads\/sites\/4\/2025\/09\/J.-Gibson_Headshot-002-221x300.jpg\" alt=\"Male in Navy blazer with blue shirt standing in front of brick background.\" width=\"221\" height=\"300\" \/> J. Gibson Headshot (002)[\/caption]<p>Graduate Student<\/p><p><a href=\"mailto:jrg6@g.clemson.edu\">jrg6@g.clemson.edu<\/a><\/p><h3><strong>Biosketch<\/strong><\/h3><p>I am a second-year PhD student and graduate research assistant in the Cottle Lab at Clemson University\u2019s Bioengineering department. My research entails the elucidation of improving <em>ex vivo <\/em>gene therapy outcomes for the treatment of inherited metabolic liver diseases. I am currently leading several projects in the lab such as the role of donor age on the engraftment potential and proliferative capacity of transplanted hepatocytes, and the optimization of base-editing as an alternative to CRISPR-Cas9 therapy for liver disease treatments. Recently, I began the position of laboratory manager, guiding budget inspection and order approval as well as fostering research efficiency. I have just begun writing my literature review on the present translatability of gene therapy and am excited to continue along this path to push the frontiers of science.<\/p><h3><strong>Research Interests<\/strong><\/h3><p>I presented the poster, <em>Comparison of electroporation systems for CRISPR-Cas9 mediated gene-editing in primary hepatocytes for the correction of hereditary tyrosinemia type 1, <\/em>in the 2024 SC INBRE Science Symposium. I am also listed as a co-author on the research article, <em>One Shock, Not One Cure: Electroporation Reveals Disease-Specific Constraints in Hepatocyte Gene Editing Therapy <\/em>and as co-primary author on the peer-reviewed research article, <em>Validation of clinical-grade electroporation systems for CRISPR-Cas9 mediated gene therapy in primary hepatocytes for the correction of inherited metabolic liver disease<\/em>.<\/p>","_et_gb_content_width":"","footnotes":"","_links_to":"","_links_to_target":""},"categories":[14,1],"tags":[],"class_list":["post-2192","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-students","category-uncategorized"],"_links":{"self":[{"href":"https:\/\/scienceweb.clemson.edu\/ihg\/wp-json\/wp\/v2\/posts\/2192","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/scienceweb.clemson.edu\/ihg\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/scienceweb.clemson.edu\/ihg\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/scienceweb.clemson.edu\/ihg\/wp-json\/wp\/v2\/users\/32"}],"replies":[{"embeddable":true,"href":"https:\/\/scienceweb.clemson.edu\/ihg\/wp-json\/wp\/v2\/comments?post=2192"}],"version-history":[{"count":0,"href":"https:\/\/scienceweb.clemson.edu\/ihg\/wp-json\/wp\/v2\/posts\/2192\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/scienceweb.clemson.edu\/ihg\/wp-json\/wp\/v2\/media\/2189"}],"wp:attachment":[{"href":"https:\/\/scienceweb.clemson.edu\/ihg\/wp-json\/wp\/v2\/media?parent=2192"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/scienceweb.clemson.edu\/ihg\/wp-json\/wp\/v2\/categories?post=2192"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/scienceweb.clemson.edu\/ihg\/wp-json\/wp\/v2\/tags?post=2192"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}